Emma Andrus, Associate Editor

Earlier this week, we shared our third Skin Cancer Awareness Month quiz. Review the answers and your responses below.

Tiffani Botts Massey, PA-C, Florida Society of Dermatology PAs President Elect, and Heather Gates, PA-C, the organization's current president, preview the upcoming conference.

Scores for erythema, dryness, quality of life, and aesthetic improvement were all markedly improved in patients using tranexamic acid versus traditional therapy alone.

VYNE Therapeutics' Iain Stuart, PhD, spoke with Dermatology Times to discuss recent phase 1 and pre-clinical data for VYN201 for vitiligo.

Researchers from NYU Langone recently published a study clarifying the role of HIF-1-alpha in inflammation and psoriasis, which has been unclear until now.

Ayesha Patrick, the founder of Sistas With Psoriasis, spoke with Dermatology Times about her involvement in AbbVie's Clearly Me campaign.

A large amount of studies included in the review centered around the use of botulinum toxin in these indications.

In recognition of Skin Cancer Awareness Month, Dermatology Times is reviewing research and strides in skin cancer treatment over the last decade.

Discover pearls on caring for patients with STDs, using dermatopathology in SOC, managing inflammatory skin conditions in women, and ensuring patients are able to access care needed.

Click here to read more and answer our quiz questions in recognition of Skin Cancer Awareness Month.

Keep up with the latest headlines in dermatology from the past week, including Johnson & Johnson's acquisition of Proteologix, a review of sunscreen approvals and efficacy, and more.

Clearly Me uses portraiture to spotlight the journeys of psoriasis patients Katie Lowes, DaQuane Cherry, Ayesha Patrick, and Joanna “JoJo” Pomerantz.

Earlier this week, we shared our second Skin Cancer Awareness Month quiz. Review the answers and your responses below.

Researchers reviewed research into the medical and toxicological viewpoints of tattooing the skin from the past decade.

The results are both confirmatory and extend the response results from a prior phase 3 trial known as FLASH.

These results are indicative of the need for dermatologists to discuss social media misinformation and low quality information with their patients.

Researchers say addressing socioeconomic differences may be the key to addressing this disparity.

Researchers found that abrocitinib demonstrated rapid, sustained, and deep improvements in several important domains of itch-dominant AD.

In a comparison of pediatric dermatologists versus AI, dermatologists primarily exhibited greater performance.

Mark Lebwohl, MD, and Saakshi Khattri, MD, discuss the evolving landscape of plaque psoriasis treatments over the past year.

This Skin Cancer Awareness Month, take a look at previous coverage from 2024.

Click here to read more and answer our quiz questions in recognition of Skin Cancer Awareness Month.

This Mother's Day, we are reviewing the interconnected relationships between pregnancy, breastfeeding, skin conditions, and managing dermatoses.

Keep up with the latest headlines in dermatology from the past week, including a California bill proposing banning the sale of anti-aging products to children, collaborative skin cancer awareness efforts, and more.

Earlier this week, we shared our first Skin Cancer Awareness Month quiz. Review the answers and your responses below.

Patients with AD experienced significant impacts to disease severity, disease control, and quality of life regardless of lesion location count.

This Skin Cancer Awareness Month, we have compiled a list of resources for clinicians to share with their patients.

Researchers explored the risk of SPM in patients of different races with the rare type of tumor of the skin.

Topical Bacitracin, Neosporin, and Vaseline were applied to mice over a 6-week period.

Aaron Farberg, MD, discusses the low-dose, affordable Accutane treatment and Clear Health’s mission to improve patient access to affordable acne therapies.